A nonradioisotope biomedical assay for intact oligonucleotide and its chain-shortened metabolites used for determination of exposure and elimination half-life of antisense drugs in tissue
Rs. Geary et al., A nonradioisotope biomedical assay for intact oligonucleotide and its chain-shortened metabolites used for determination of exposure and elimination half-life of antisense drugs in tissue, ANALYT BIOC, 274(2), 1999, pp. 241-248
Rigorous extraction methods coupled with capillary gel electrophoresis (CGE
) provide a basis for a nonradiolabel assay for quantitation of intact anti
sense drug and its numerous chain-shortened metabolites. As part of the val
idation of the CGE method, we compared the quantitation of unlabeled ISIS 3
521 (ISI 641A) and its chain-shortened metabolites with total radioactivity
of [S-35]-ISIS 3521, ISIS 3521 was labeled on the fifth nucleotide linkage
from the 5'-end with S-35 by well-established methods. Multiple tissues co
llected from rats after administration of [35S]-ISIS 3521 were assayed by b
oth radiolabel (liquid scintillation spectroscopy) and CGE methods. The CGE
method provided accurate quantitation of the drug and its metabolites in k
idney cortex and liver tissues. The correlation between methods for multipl
e tissues over time was excellent with 88.5% of the measurements being stat
istically equivalent. These data suggest that CGE is an accurate means of q
uantitating oligonucleotide in tissue and that it compares favorably with t
raditional radiochemical techniques, Clearance half-lives for total measura
ble oligonucleotides were equivalent to clearance of total radioactivity in
both liver and kidney with the longest clearance half-life associated with
the kidney, (C) 1999 Academic Press.